Estimating the distribution of nonterminal event time in the presence of mortality or informative dropout

被引:16
作者
Jiang, HY
Chappell, R
Fine, JP
机构
[1] Harvard Univ, Dept Biostat, Boston, MA 02115 USA
[2] Harvard Univ, Ctr Biostat AIDS Res, Boston, MA 02115 USA
[3] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA
[4] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA
来源
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷 / 02期
关键词
bivariate survival analysis; Clayton model; dependent censoring; semicompeting risks data;
D O I
10.1016/S0197-2456(02)00307-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We consider estimating the distribution of nonterminal event time that may be censored by a terminal event but not vice versa. This problem may arise in two scenarios: (1) clinical trials involving both terminal and nonterminal events, or (2) when the primary outcome of the trial is nonterminal but there exists informative dropout. Inference is complicated by the dependent censoring from. mortality or informative dropout. In this paper, we show that the joint distribution of the events can be formulated such that only the association is parameterized, with the marginal distributions unspecified. A closed form estimator for the association parameter is obtained from a novel adaptation of Oakes' concordance estimating equation. Tests for independence and goodness-of-fit of the model are also developed. A computationally simple, consistent and asymptotically normal estimator for the marginal distribution of the nonterminal event is given. Simulations demonstrate that the methods work well with practical sample sizes. The proposals are illustrated with data from an AIDS clinical trial. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 26 条
[1]   Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection. [J].
Albrecht, MA ;
Bosch, RJ ;
Hammer, SM ;
Liou, SH ;
Kessler, H ;
Para, MF ;
Eron, J ;
Valdez, H ;
Dehlinger, M ;
Katzenstein, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06) :398-407
[2]  
Andersen P. K., 2012, Statistical models based on counting processes
[3]   WHY ACTUARIAL ESTIMATES SHOULD BE USED IN REPORTING LATE NORMAL-TISSUE EFFECTS OF CANCER-TREATMENT ... NOW [J].
BENTZEN, SM ;
VAETH, M ;
PEDERSEN, DE ;
OVERGAARD, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (05) :1531-1534
[4]  
Caplan R. J., 1996, INT J RADIAT ONCOL, V35, P1547
[5]   WHY ACTUARIAL ESTIMATES SHOULD BE USED IN REPORTING LATE NORMAL-TISSUE EFFECTS OF CANCER-TREATMENT ... NOW - RESPONSE [J].
CAPLAN, RJ ;
PAJAK, TF ;
COX, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (05) :1547-1547
[6]   Preoperative radiotherapy in rectal cancer: Are all protocols comparable? [J].
Chappell, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (04) :988-989
[7]  
CLAYTON DG, 1978, BIOMETRIKA, V65, P141, DOI 10.1093/biomet/65.1.141
[8]   TREATMENT FOR ACUTE MYELOCYTIC-LEUKEMIA WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOLLOWING PREPARATION WITH BUCY2 [J].
COPELAN, EA ;
BIGGS, JC ;
THOMPSON, JM ;
CRILLEY, P ;
SZER, J ;
KLEIN, JP ;
KAPOOR, N ;
AVALOS, BR ;
CUNNINGHAM, I ;
ATKINSON, K ;
DOWNS, K ;
HARMON, GS ;
DALY, MB ;
BRODSKY, I ;
BULOVA, SI ;
TUTSCHKA, PJ .
BLOOD, 1991, 78 (03) :838-843
[9]   Adaptation of bivariate frailty models for prediction, with application to biological markers as prognostic indicators [J].
Day, R ;
Bryant, J .
BIOMETRIKA, 1997, 84 (01) :45-56
[10]   Regarding actuarial late effect analyses [J].
Denham, JW ;
Hamilton, CS ;
OBrien, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (01) :197-197